vs

Side-by-side financial comparison of IES Holdings, Inc. (IESC) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

IES Holdings, Inc. is the larger business by last-quarter revenue ($871.0M vs $622.0M, roughly 1.4× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 10.5%, a 23.9% gap on every dollar of revenue. On growth, IES Holdings, Inc. posted the faster year-over-year revenue change (16.2% vs 4.8%). Over the past eight quarters, IES Holdings, Inc.'s revenue compounded faster (11.1% CAGR vs 4.6%).

IES Holdings, Inc., formerly known as Integrated Electrical Services, Inc., designs and installs integrated electrical and technology systems and provides infrastructure products and services to a variety of end markets, including data centers, residential housing, and commercial and industrial facilities.

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

IESC vs RPRX — Head-to-Head

Bigger by revenue
IESC
IESC
1.4× larger
IESC
$871.0M
$622.0M
RPRX
Growing faster (revenue YoY)
IESC
IESC
+11.4% gap
IESC
16.2%
4.8%
RPRX
Higher net margin
RPRX
RPRX
23.9% more per $
RPRX
34.4%
10.5%
IESC
Faster 2-yr revenue CAGR
IESC
IESC
Annualised
IESC
11.1%
4.6%
RPRX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
IESC
IESC
RPRX
RPRX
Revenue
$871.0M
$622.0M
Net Profit
$91.8M
$214.2M
Gross Margin
25.3%
Operating Margin
11.2%
62.4%
Net Margin
10.5%
34.4%
Revenue YoY
16.2%
4.8%
Net Profit YoY
59.1%
2.9%
EPS (diluted)
$4.51
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IESC
IESC
RPRX
RPRX
Q4 25
$871.0M
$622.0M
Q3 25
$897.8M
$609.3M
Q2 25
$890.2M
$578.7M
Q1 25
$834.0M
$568.2M
Q4 24
$749.5M
$593.6M
Q3 24
$775.8M
$564.7M
Q2 24
$768.4M
$537.3M
Q1 24
$705.7M
$568.0M
Net Profit
IESC
IESC
RPRX
RPRX
Q4 25
$91.8M
$214.2M
Q3 25
$102.3M
$288.2M
Q2 25
$79.3M
$30.2M
Q1 25
$72.6M
$238.3M
Q4 24
$57.7M
$208.2M
Q3 24
$65.5M
$544.0M
Q2 24
$66.6M
$102.0M
Q1 24
$56.8M
$4.8M
Gross Margin
IESC
IESC
RPRX
RPRX
Q4 25
25.3%
Q3 25
26.0%
Q2 25
26.9%
Q1 25
25.0%
Q4 24
23.8%
Q3 24
24.0%
Q2 24
25.3%
Q1 24
24.3%
Operating Margin
IESC
IESC
RPRX
RPRX
Q4 25
11.2%
62.4%
Q3 25
11.6%
70.1%
Q2 25
12.6%
36.3%
Q1 25
11.1%
94.0%
Q4 24
10.0%
60.9%
Q3 24
9.7%
Q2 24
11.7%
50.2%
Q1 24
11.0%
-13.0%
Net Margin
IESC
IESC
RPRX
RPRX
Q4 25
10.5%
34.4%
Q3 25
11.4%
47.3%
Q2 25
8.9%
5.2%
Q1 25
8.7%
41.9%
Q4 24
7.7%
35.1%
Q3 24
8.4%
96.3%
Q2 24
8.7%
19.0%
Q1 24
8.0%
0.8%
EPS (diluted)
IESC
IESC
RPRX
RPRX
Q4 25
$4.51
$0.49
Q3 25
$4.99
$0.67
Q2 25
$3.81
$0.07
Q1 25
$3.50
$0.55
Q4 24
$2.72
$0.46
Q3 24
$3.06
$1.21
Q2 24
$2.67
$0.23
Q1 24
$2.29
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IESC
IESC
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$258.7M
$618.7M
Total DebtLower is stronger
$9.0B
Stockholders' EquityBook value
$961.1M
$9.7B
Total Assets
$1.7B
$19.6B
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IESC
IESC
RPRX
RPRX
Q4 25
$258.7M
$618.7M
Q3 25
$231.8M
$938.9M
Q2 25
$168.3M
$631.9M
Q1 25
$88.3M
$1.1B
Q4 24
$112.0M
$929.0M
Q3 24
$135.8M
$950.1M
Q2 24
$44.9M
$1.8B
Q1 24
$106.0M
$843.0M
Total Debt
IESC
IESC
RPRX
RPRX
Q4 25
$9.0B
Q3 25
$8.9B
Q2 25
$8.0B
Q1 25
$7.6B
Q4 24
$7.6B
Q3 24
$7.6B
Q2 24
$7.6B
Q1 24
$6.1B
Stockholders' Equity
IESC
IESC
RPRX
RPRX
Q4 25
$961.1M
$9.7B
Q3 25
$884.0M
$9.6B
Q2 25
$781.4M
$9.5B
Q1 25
$705.8M
$9.8B
Q4 24
$652.4M
$10.3B
Q3 24
$611.1M
$10.3B
Q2 24
$567.5M
$9.8B
Q1 24
$534.8M
$9.9B
Total Assets
IESC
IESC
RPRX
RPRX
Q4 25
$1.7B
$19.6B
Q3 25
$1.6B
$19.3B
Q2 25
$1.5B
$18.3B
Q1 25
$1.4B
$17.6B
Q4 24
$1.3B
$18.2B
Q3 24
$1.2B
$18.0B
Q2 24
$1.2B
$17.7B
Q1 24
$1.1B
$16.1B
Debt / Equity
IESC
IESC
RPRX
RPRX
Q4 25
0.92×
Q3 25
0.93×
Q2 25
0.84×
Q1 25
0.78×
Q4 24
0.74×
Q3 24
0.74×
Q2 24
0.78×
Q1 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IESC
IESC
RPRX
RPRX
Operating Cash FlowLast quarter
$27.7M
$827.1M
Free Cash FlowOCF − Capex
$-18.9M
FCF MarginFCF / Revenue
-2.2%
Capex IntensityCapex / Revenue
5.3%
Cash ConversionOCF / Net Profit
0.30×
3.86×
TTM Free Cash FlowTrailing 4 quarters
$175.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IESC
IESC
RPRX
RPRX
Q4 25
$27.7M
$827.1M
Q3 25
$132.0M
$702.6M
Q2 25
$92.0M
$364.0M
Q1 25
$24.8M
$596.1M
Q4 24
$37.3M
$742.5M
Q3 24
$92.8M
$703.6M
Q2 24
$82.9M
$658.2M
Q1 24
$33.7M
$664.6M
Free Cash Flow
IESC
IESC
RPRX
RPRX
Q4 25
$-18.9M
Q3 25
$112.0M
Q2 25
$74.8M
Q1 25
$7.9M
Q4 24
$24.1M
Q3 24
$78.5M
Q2 24
$65.4M
Q1 24
$26.9M
FCF Margin
IESC
IESC
RPRX
RPRX
Q4 25
-2.2%
Q3 25
12.5%
Q2 25
8.4%
Q1 25
0.9%
Q4 24
3.2%
Q3 24
10.1%
Q2 24
8.5%
Q1 24
3.8%
Capex Intensity
IESC
IESC
RPRX
RPRX
Q4 25
5.3%
Q3 25
2.2%
Q2 25
1.9%
Q1 25
2.0%
Q4 24
1.8%
Q3 24
1.8%
Q2 24
2.3%
Q1 24
1.0%
Cash Conversion
IESC
IESC
RPRX
RPRX
Q4 25
0.30×
3.86×
Q3 25
1.29×
2.44×
Q2 25
1.16×
12.06×
Q1 25
0.34×
2.50×
Q4 24
0.65×
3.57×
Q3 24
1.42×
1.29×
Q2 24
1.24×
6.45×
Q1 24
0.59×
139.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IESC
IESC

Communications$351.9M40%
Single Family Electrical Contracts$137.0M16%
Custom Engineered Solutions$116.0M13%
Commercialand Industrial$94.8M11%
Single Family Contracts Plumbing HVAC$82.9M10%
Multi Familyand Other$64.2M7%
Industrial Services$24.2M3%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons